Menu Search
Equities

Align Technology Inc

AFW:BRN

Align Technology Inc

Actions
  • Price (CHF)186.79
  • Today's Change0.00 / 0.00%
  • Shares traded10.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 29 2022.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Align Technology, Inc. is a global medical device company. The Company is engaged in the design, manufacture and marketing of Invisalign clear aligners, iTero intraoral scanners and services for dentistry, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for dental laboratories and dental practitioners. It operates through two segments: Clear Aligner, and Systems and Services. Its Clear Aligner segment consists of Comprehensive Products, which includes Invisalign Comprehensive and Invisalign First; Non-Comprehensive Products, which includes Invisalign Moderate, Lite and Express packages and Invisalign Go and Invisalign Go Plus, and Non-Case products, which include retention products, Invisalign training, adjusting tools used by dental professionals during the course of treatment and consumer products that are complementary to its doctor-prescribed principal products. Its Systems and Services segment consists of its iTero intraoral scanning systems.

  • Revenue in USD (TTM)3.73bn
  • Net income in USD361.57m
  • Incorporated1997
  • Employees23.17k
  • Location
    Align Technology Inc410 North Scottsdale Road, Suite 1300TEMPE 85288United StatesUSA
  • Phone+1 (408) 470-1000
  • Fax+1 (408) 470-1010
  • Websitehttps://www.aligntech.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.